Rebecca Wilsker

About

Rebecca Wilsker is a strategic, solution-oriented corporate attorney who advises US, UK, and European clients on matters ranging from significant transactions to day-to-day needs. A US-qualified lawyer with significant cross-border experience, Rebecca focuses her practice on providing practical, actionable advice to private companies and investors on critical transactions, including M&A, equity financings, partnerships, and other life cycle events.

She also advises companies on corporate governance matters, equity compensation, financings, and commercial transactions. While Rebecca’s clients come from a variety of industries, she works extensively with tech and tech-enabled businesses. Clients appreciate Rebecca’s creative and practical approach to getting deals done, noting that her team-oriented style and business savvy puts investors, founders, and management teams at ease.

Rebecca was named in “Top 25 in ’25: Women in Technology Investing” by the Kayo Conference Series, has been listed in The Legal 500 USA, M&A/Corporate and Commercial – Private Equity Buyouts: Middle-Market (up to $500M), and has been named a “Rising Star” by her native Massachusetts Super Lawyers magazine annually since 2014.

Before joining Burges Salmon, Rebecca spent 15 years at leading US law firms, most recently as a Partner at Holland & Knight LLP.

Experience

• Represented a Belgian provider of cloud-based compliance tools backed by UK private equity in a its acquisition of a US-based provider of EHS compliance solutions and other US corporate matters.
• Advised a UK private equity backed franchisor of quick service restaurants on US matters and in multiple transactions involving acquisition of franchising rights and other assets in the US.
• Represented a UK private equity fund on its acquisition of a US risk management platform in a carve-out from a US not-for-profit entity.
• Represented a US private equity fund in a roll-up acquisition of multiple cybersecurity services and software companies.
• Represented a PE-backed healthcare technology company in its sale to a private equity buyer.
• Acted as US counsel to a UK private equity fund in its acquisition of an Ireland-based medical device manufacturer.

Credentials

• Admitted as an Attorney-at-Law: Massachusetts, USA (2011)